635 related articles for article (PubMed ID: 27491568)
1. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.
Musset L; Allenbach Y; Benveniste O; Boyer O; Bossuyt X; Bentow C; Phillips J; Mammen A; Van Damme P; Westhovens R; Ghirardello A; Doria A; Choi MY; Fritzler MJ; Schmeling H; Muro Y; García-De La Torre I; Ortiz-Villalvazo MA; Bizzaro N; Infantino M; Imbastaro T; Peng Q; Wang G; Vencovský J; Klein M; Krystufkova O; Franceschini F; Fredi M; Hue S; Belmondo T; Danko K; Mahler M
Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568
[TBL] [Abstract][Full Text] [Related]
2. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
Shovman O; Gilburd B; Chayat C; Lazar AD; Amital H; Blank M; Bentow C; Mahler M; Shoenfeld Y
Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830
[TBL] [Abstract][Full Text] [Related]
3. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.
Mohassel P; Mammen AL
Muscle Nerve; 2013 Oct; 48(4):477-83. PubMed ID: 23519993
[TBL] [Abstract][Full Text] [Related]
4. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy.
Limaye V; Bundell C; Hollingsworth P; Rojana-Udomsart A; Mastaglia F; Blumbergs P; Lester S
Muscle Nerve; 2015 Aug; 52(2):196-203. PubMed ID: 25521389
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.
Mammen AL; Chung T; Christopher-Stine L; Rosen P; Rosen A; Doering KR; Casciola-Rosen LA
Arthritis Rheum; 2011 Mar; 63(3):713-21. PubMed ID: 21360500
[TBL] [Abstract][Full Text] [Related]
6. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
[TBL] [Abstract][Full Text] [Related]
7. Identifying statin-associated autoimmune necrotizing myopathy.
Albayda J; Christopher-Stine L
Cleve Clin J Med; 2014 Dec; 81(12):736-41. PubMed ID: 25452351
[TBL] [Abstract][Full Text] [Related]
8. Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience.
Klein M; Mann H; Pleštilová L; Zámečník J; Betteridge Z; McHugh N; Vencovský J
Rheumatology (Oxford); 2015 Nov; 54(11):2010-4. PubMed ID: 26109604
[TBL] [Abstract][Full Text] [Related]
9. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.
Watanabe Y; Suzuki S; Nishimura H; Murata KY; Kurashige T; Ikawa M; Asahi M; Konishi H; Mitsuma S; Kawabata S; Suzuki N; Nishino I
Medicine (Baltimore); 2015 Jan; 94(4):e416. PubMed ID: 25634171
[TBL] [Abstract][Full Text] [Related]
10. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
[TBL] [Abstract][Full Text] [Related]
11. Immune-mediated necrotizing myopathy due to statins exposure.
Villa L; Lerario A; Calloni S; Peverelli L; Matinato C; DE Liso F; Ceriotti F; Tironi R; Sciacco M; Moggio M; Triulzi F; Cinnante C
Acta Myol; 2018 Dec; 37(4):257-262. PubMed ID: 30944904
[TBL] [Abstract][Full Text] [Related]
12. [Two cases of statin-induced immune-mediated necrotizing myopathy].
Safi T; Wagner H
Lakartidningen; 2021 Dec; 118():. PubMed ID: 34861042
[TBL] [Abstract][Full Text] [Related]
13. Immune-mediated necrotizing myopathy associated with statins: history and recent developments.
Tiniakou E; Christopher-Stine L
Curr Opin Rheumatol; 2017 Nov; 29(6):604-611. PubMed ID: 28857949
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous involvement in anti-HMGCR positive necrotizing myopathy.
Williams B; Horn MP; Banz Y; Feldmeyer L; Villiger PM
J Autoimmun; 2021 Sep; 123():102691. PubMed ID: 34332436
[TBL] [Abstract][Full Text] [Related]
16. Statins and myositis: the role of anti-HMGCR antibodies.
Selva-O'Callaghan A; Alvarado-Cardenas M; Marin A; Pinal-Fernandez I
Expert Rev Clin Immunol; 2015; 11(12):1277-9. PubMed ID: 26492593
[TBL] [Abstract][Full Text] [Related]
17. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
[TBL] [Abstract][Full Text] [Related]
18. [Immune-mediated necrotizing myopathy associated with antibodies to hydroxy-methyl-glutaryl-coenzyme A reductase].
Hinschberger O; Lohmann C; Lannes B; Martzolff L; Vo BD; Jaeger-Bizet F; Ciobanu E; Kieffer P
Rev Med Interne; 2014 Aug; 35(8):546-9. PubMed ID: 23910221
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies.
Ge Y; Lu X; Peng Q; Shu X; Wang G
PLoS One; 2015; 10(10):e0141616. PubMed ID: 26509687
[TBL] [Abstract][Full Text] [Related]
20. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
Ladislau L; Arouche-Delaperche L; Allenbach Y; Benveniste O
Curr Rheumatol Rep; 2018 Aug; 20(9):56. PubMed ID: 30074107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]